Axial disease in psoriatic arthritis

被引：105
作者：
Gladman D.D. [1 ]
机构：
[1] Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ont. M5T 2S8, 399 Bathurst Street
来源：
Current Rheumatology Reports | 2007年 / 9卷 / 6期
关键词：
Psoriasis; Psoriatic Arthritis; Axial Disease; ESSG Criterion;
D O I：
10.1007/s11926-007-0074-2
中图分类号：
学科分类号：
摘要：
The definition of axial disease in psoriatic arthritis has varied from isolated unilateral grade 2 sacroiliitis to criteria similar to those used for ankylosing spondylitis. Depending on the definition used, the prevalence of axial disease varies from 25% to 70% of patients with psoriatic arthritis. This article reviews the prevalence, clinical and radiologic features, pathogenesis, prognosis, and treatment of psoriatic spondylitis. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：455 / 460
页数：5
相关论文
共 40 条
[1]  
Wright V., Psoriasis and arthritis, Ann Rheum Dis, 15, pp. 348-353, (1956)
[2]  
Wright V., Moll J.M., Psoriatic arthritis, Seronegative Polyarthritis, pp. 169-223, (1976)
[3]  
Dougados M., van der Linden S., Juhlin R., Et al., The Euro pean Spondylarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy, Arthritis Rheum, 34, pp. 1218-1227, (1991)
[4]  
Taylor W.J., Zmierczak H.G., Helliwell P.S., Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis, J Rheumatol, 32, pp. 974-977, (2005)
[5]  
Buskila D., Langevitz P., Gladman D.D., Et al., Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis, J Rheumatol, 19, pp. 1115-1119, (1992)
[6]  
Gladman D.D., Brubacher B., Buskila D., Et al., Differences in the expression of spondyloarthropathy: A comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects, Clin Invest Med, 16, pp. 1-7, (1993)
[7]  
Trontzas P., Andrianakos A., Miyakis S., Et al., Seronegative spondyloarthropathies in Greece: A population-based study of prevalence, clinical pattern, and management. The ESORDIG study, Clin Rheumatol, 24, pp. 583-589, (2005)
[8]  
Saraux A., Guillemin F., Guggenbuhl P., Et al., Prevalence of spondyloarthropathies in France: 2001, Ann Rheum Dis, 64, pp. 1431-1435, (2005)
[9]  
De Angelis R., Salaffi F., Grassi W., Prevalence of spondyloarthropathies in an Italian population sample: A regional community-based study, Scand J Rheumatol, 36, pp. 14-21, (2007)
[10]  
Hanly J.G., Russell M.L., Gladman D.D., Psoriatic spondyloarthropathy: A long term prospective study, Ann Rheum Dis, 47, pp. 386-393, (1988)
1234